In ESCC tissue, amplification of genes such as WTIP and MCL1 (chromosome 19) may enhance tumor invasiveness and anti-apoptotic capacities, potentially influencing tumor progression and therapeutic response (13, 14). Here, MCL1 is linked to esophageal squamous cell carcinoma.